Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-18

Clinical Trial Update: Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial assessing fludarabine with or without cyclophosphamide in chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Fludarabine (Fludarabine)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia | Phase 3 | Status: COMPLETED